From Reliance to Defiance: A Decade-Long Panorama of China's Innovative Drug Transactions
The third report in PharmCube's 10th Anniversary Series, From Reliance to Defiance: A Decade-Long Panorama of China's Innovative Drug Transactions, unveils for the first time ten years of transaction data in China's innovative drug sector. Drawing on authoritative sources such as PharmCube's NextPharma® database, the report systematically reviews global and Chinese pharmaceutical transactions from 2015 to 2024. It focuses on transaction volume, the evolution of deal models, key participants, and representative case studies. The aim is to reveal the transformation path of China's innovative pharmaceutical industry and provide strategic insights for industry stakeholders.